BMI1 and cancer: We tested this hypothesis by evaluating the effects of Bmi-1 inhibition by shRNA on DNA damage, apoptosis, mitochondrial membrane potential (ΔΨm) and apoptosis related protein for the purpose of a more improved cancer therapy.